Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza

NCT03903718 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated due to delay in site enrollment timelines

Conditions

Influenza

Interventions

DRUG: Oseltamivir
BIOLOGICAL: MEDI8852
DRUG: Placebo

Sponsor

MedImmune LLC